Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01776398 · ClinicalTrials.gov registry record

Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies

A clinical trial of Smoking Cessation and Smoking, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
2,000
Enrollment target
1
Study location

NCT01776398: Recruiting study of Smoking Cessation and Smoking, sponsored by Weill Medical College of Cornell University.

NCT01776398 is a study of Smoking Cessation and Smoking that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 2,000 participants, above the 464-participant average among 188 other Smoking Cessation trials with a reported enrollment target (331% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01776398, a study of Smoking Cessation and Smoking, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
2,000 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to obtain biologic materials from the blood, airways and/or urine of normal individuals and individuals with lung disease. The normal are used to establish a set of normal ranges for various parameters. These provide control information when compared to individuals with various pulmonary diseases, and will help in understanding of the etiology and pathogenesis of various lung diseases. The underlying hypothesis is that the pathologic morphological changes in the airway epithelium must be preceded by changes in the gene expression pattern of the airway epithelium and potentially in macrophages.

Primary Outcome

The primary objective of the study is to obtain biologic materials from the blood, airways and/or urine of normal individuals and individuals with lung disease. The normal are used to establish a set of normal ranges for various parameters. These provide control information when compared to individuals with various pulmonary diseases, and will help in understanding the etiology and pathogenesis of various lung diseases.

Conditions Studied

Smoking Cessation Smoking Chronic Obstructive Pulmonary Disease (COPD) Idiopathic Pulmonary Fibrosis (IPF) Rheumatoid Arthritis-Associated Interstitial Lung Disease Scleroderma-Associated Interstitial Lung Disease (SSC-ILD)

Study Locations (1)

New York

  • Weill Cornell Medical College and Weill Cornell Medical Center, Department of Genetic Medicine - New York

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2012-08-29
Est. Completion 2028-12
Weill Medical College of Cornell University

701 total trials

What NCT01776398 shows while recruiting

NCT01776398 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 464-participant average among 188 other Smoking Cessation trials with a reported enrollment target (331% higher).

The record links to 6 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 0 interventions.

NCT01776398 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT01776398 about?

NCT01776398 is a clinical study titled "Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies". The purpose of this study is to obtain biologic materials from the blood, airways and/or urine of normal individuals and individuals with lung disease. The normal are used to establish a set of normal ranges for various parameters. These provide control information when compared to individuals with ...

What is the current status of trial NCT01776398?

This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2012-08-29. Estimated completion is 2028-12.

What conditions does trial NCT01776398 study?

This clinical trial studies the following conditions: Smoking Cessation, Smoking, Chronic Obstructive Pulmonary Disease (COPD), Idiopathic Pulmonary Fibrosis (IPF), Rheumatoid Arthritis-Associated Interstitial Lung Disease.

Who is sponsoring clinical trial NCT01776398?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01776398 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Smoking Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01776398's enrollment target sits among peer trials

2,000 7th of 188 higher than 181 of 188 other Smoking Cessation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001465 · 2,000 participants

    Study of the Disease Process of Lymphangioleiomyomatosis

  • NCT00001595 · 2,000 participants

    An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

  • NCT00138931 · 2,000 participants

    Genetics of Cardiovascular and Neuromuscular Disease

  • NCT00288119 · 2,000 participants

    Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT01776398

Source: ClinicalTrials.gov NCT01776398, the US trial registry maintained by the National Library of Medicine. NCT01776398 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.